Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products; Draft Guidance for Industry; Availability
FDA-2026-D-2839-0001Notice
Document
Details
The document's own metadata, straight from the source system.
- Title
- Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products; Draft Guidance for Industry; Availability
- Posted
- Jun 1, 2026
- Topics